MOATAZEDI DAVID
SEC CIK 1700836 · EDGAR
BoughtSold
Most active insiders at EOLS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MOATAZEDI DAVID | See Remarks, Dir | — | $1.66M |
| 2 | Avelar Rui | See Remarks | — | $177.7K |
| 3 | Mitchell Tatjana | CFO | — | — |
| 4 | Stewart Brady | Dir | — | — |
| 5 | Malik Vikram | Dir | — | — |
| 6 | Parschauer Karah Herdman | Dir | — | — |
| 7 | White Albert G III | Dir | — | — |
| 8 | GILL DAVID N | Dir | — | — |
Transactions 36
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-04 19:04 | 2026-09-02 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $9.04 | -105.1K | 499.6K | -17% | -$950.0K | |
| 2026-08-27 17:26 | 2026-08-26 | BMRA | BIOMERICA INC | MOATAZEDI DAVID | Dir | P - Purchase | $1.60 | +10.0K | 40.6K | +33% | +$16.0K | |
| 2026-03-20 | 2026-03-20 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $4.75 | -13.7K | 604.7K | -2% | -$64.9K | |
| D | 2026-03-18 | 2026-03-17 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale+OE | $4.89 | -116.7K | 618.4K | -16% | -$570.8K |
| D | 2026-03-18 | 2026-03-16 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | M - OptEx | $0.00 | +67.5K | 735.1K | +10% | $0 |
| D | 2026-02-19 | 2026-02-17 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +313.2K | 667.6K | +88% | $0 |
| 2025-12-31 | 2025-12-12 | BMRA | BIOMERICA INC | MOATAZEDI DAVID | Dir | A - Grant | $0.00 | +20.0K | 30.6K | +188% | $0 | |
| 2025-12-29 | 2025-12-22 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $7.15 | -10.5K | 354.4K | -3% | -$75.4K | |
| M | 2025-06-16 | 2025-06-13+ | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $10.03 | -127.9K | 381.5K | -25% | -$1.28M |
| 2025-05-14 | 2025-05-12 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $9.87 | -15.8K | 492.8K | -3% | -$155.8K | |
| 2025-03-28 | 2025-03-27 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $12.40 | -6,251 | 508.6K | -1% | -$77.5K | |
| 2025-03-20 | 2025-03-18 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.26 | -103.4K | 514.9K | -17% | -$1.37M | |
| D | 2025-03-11 | 2025-03-07 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +95.4K | 618.2K | +18% | $0 |
| 2024-12-26 | 2024-12-23 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $10.85 | -10.5K | 522.8K | -2% | -$113.9K | |
| 2024-12-17 | 2024-12-13 | BMRA | BIOMERICA INC | MOATAZEDI DAVID | Dir | A - Grant | $0.31 | +85.0K | 85.0K | New | +$26.4K | |
| DM | 2024-06-06 | 2024-06-04+ | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale+OE | $12.74 | -471.4K | 533.3K | -47% | -$6.01M |
| DM | 2024-06-06 | 2024-06-05+ | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | M - OptEx | $6.43 | +331.2K | 688.6K | +93% | +$2.13M |
| 2024-05-14 | 2024-05-10 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $12.72 | -16.1K | 673.6K | -2% | -$204.2K | |
| 2024-03-29 | 2024-03-27 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.86 | -6,236 | 689.6K | -0.9% | -$86.4K | |
| 2024-03-21 | 2024-03-19 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.92 | -96.6K | 695.9K | -12% | -$1.34M | |
| 2024-02-23 | 2024-02-22 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.08 | -7,706 | 792.4K | -1.0% | -$100.8K | |
| 2024-02-23 | 2024-02-21 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +61.2K | 800.1K | +8% | $0 | |
| D | 2024-02-09 | 2024-02-07 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +135.0K | 738.9K | +22% | $0 |
| M | 2023-12-08 | 2023-12-06+ | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $9.95 | -82.6K | 603.9K | -12% | -$822.7K |
| 2023-08-16 | 2023-08-16 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $10.27 | -14.8K | 686.6K | -2% | -$151.8K | |
| 2023-08-16 | 2023-08-14 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +91.8K | 701.4K | +15% | $0 | |
| 2023-03-29 | 2023-03-27 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $8.47 | -6,110 | 609.6K | -1.0% | -$51.8K | |
| 2023-03-16 | 2023-03-14 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $8.47 | -64.2K | 615.7K | -9% | -$543.9K | |
| D | 2023-01-27 | 2023-01-25 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +187.9K | 679.9K | +38% | $0 |
| 2022-05-18 | 2022-05-16 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $13.64 | -55.3K | 492.0K | -10% | -$754.6K | |
| 2022-03-30 | 2022-03-28 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $11.62 | -6,104 | 547.3K | -1% | -$70.9K | |
| 2022-03-10 | 2022-03-08 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $9.73 | -38.0K | 553.4K | -6% | -$369.5K | |
| D | 2022-01-26 | 2022-01-24 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | A - Grant | $0.00 | +214.3K | 591.4K | +57% | $0 |
| M | 2021-08-17 | 2021-08-13+ | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $11.13 | -70.4K | 377.1K | -16% | -$783.9K |
| A | 2021-08-12 | 2021-08-10 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $11.18 | -41.8K | 447.5K | -9% | -$466.9K |
| 2021-08-12 | 2021-08-10 | EOLS | Evolus, Inc. | MOATAZEDI DAVID | See Remarks, Dir | S - Sale | $11.18 | +41.8K | 531.0K | +9% | +$466.9K |
Purchase Sale Sale after option exercise All abbreviations